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Abstract
The thiazolinyl imine reductase from Yersinia enterocolitica (Irp3) catalyzes the NADPH-
dependent reduction of a thiazoline ring in an intermediate for the formation of the siderophore
yersiniabactin. Two structures of Irp3 were determined in the apo- (1.85 Å) and NADP+-bound
(2.31 Å) forms. Irp3 shows structural homology to sugar oxidoreductases such as glucose-fructose
oxidoreductase and 1,5-anhydro-D-fructose reductase, as well as to biliverdin reductase. A
homology model of the thiazolinyl imine reductase from Pseudomonas aeruginosa (PchG) was
generated. Extensive loop insertions are observed in the C-terminal domain that are unique to Irp3
and PchG and not found in the structural homologs that recognize small molecular substrates.
These loops are hypothesized to be important for binding of the nonribosomal peptide synthetase
modules (found in HMWP1 and PchF, respectively) to which the substrate of the reductase is
covalently attached. A catalytic mechanism of proton donation from a general acid (either
histidine-101 or tyrosine-128) and hydride donation from C4 of nicotinamide of the NADPH
cofactor is proposed for reduction of the carbon-nitrogen double bond of the thiazoline.
Pathogenic bacteria must acquire iron from the environment, since iron is an essential
element required as a cofactor by the enzymes of many pathways, including electron
transport, DNA synthesis, and the tricarboxylic acid cycle. A typical bacterium requires ~1
μM iron for optimal growth, but the concentration of available iron in the human host is
~10-9 μM (1). In addition, Fe(III) is very insoluble and frequently biologically inaccessible.
For pathogenic bacteria, this requirement is a significant obstacle to overcome. Therefore,
bacteria have developed elaborate systems to scavenge iron from the environment/host (2).
One such system is the use of siderophores: low molecular weight iron chelators, which the
bacteria synthesize, secrete, and then selectively take up in the iron-loaded form to survive
and colonize human tissues (2-4).
Yersinia and Pseudomonas spp. produce salicyl-capped siderophores that contain thiazoline
and thiazolidine rings, both derived from cyclized cysteines (Figure 1). The latter ring is
reduced from the thiazoline by an NADPH-dependent reductase, possibly to attain the
appropriate geometry to coordinate ferric iron (5). Two enzymes that catalyze this reduction
are the focus of this study, in particular Irp3 from Yersinia enterocolitica and PchG from
Pseudomonas aeruginosa, which share 26% sequence identity. The homologue from
Yersinia pestis, YbtU, is different from Irp3 at 8 of 365 amino acids (98% sequence
identity). YbtU was originally identified as required for yersiniabactin formation, but with
an unknown role (6). A sequence analysis suggested that there was a possible
transmembrane helix from residues 162 to 182 (6).
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Functional characterization of PchG showed that the enzyme was a required reductase for
pyochelin maturation that produced an intermediate, desmethyl-pyochelin, in which the
second thiazoline ring is reduced (Figure 1) (7). The substrate for PchG, a hydroxyphenyl-
bisthiazolinyl precursor of pyochelin, is covalently attached to the peptidyl carrier domain of
PchF, a nonribosomal peptide synthetase (NRPS), through a phosphopantetheinyl (Ppant)
post translation modification of a serine (Figure 1b) (7). A complete in vitro reconstitution
for the production of pyochelin required PchD (a salicylate adenylase), PchE and PchF (two
nonribosomal peptide synthetases modified to have the pPant group), PchG, NADPH, S-
adenosylmethionine, ATP, coenzyme A, cysteine and salicylate (5). The authors noted that
PchG showed weak sequence similarity to biliverdin reductase (BVR) and proposed a
mechanism of hydride transfer from the NADPH cofactor followed by protonation of the
nitrogen of the developing thiazolidine (5). The N-terminal portion of PchG was
hypothesized to be structurally similar to the C-terminal portion of mouse major urinary
protein, which had been determined with 2-(sec-butyl)thiazoline bound (5). A similar role
for the reduction of the second thiazoline ring of yersiniabactin was subsequently shown for
YbtU when the substrate is Ppant-tethered to the peptidyl carrier domain of the NRPS
module of the High Molecular Weight Protein 1 (HMWP1) (Figure 1a) (8). Kinetic
measurements for PchG, YbtU, and Irp3 are complicated by the nature of the substrate: an
immature siderophore covalently tethered to an NRPS. Therefore, a next viable step for
understanding these enzymes is acquiring structural information to provide context for
catalysis and protein-protein interactions.
Here we present the first structural characterization of an NADPH-dependent thiazolinyl
imine reductase with the structures of apo- and NADP+-bound Irp3. We also present the
homology model of PchG. We propose an interaction motif for Irp3 and PchG with the
nonribosomal peptide synthetase modules to which their substrates are covalently attached.
We further propose a catalytic mechanism based on the structures and by analogy to the
closest structural homologues of known function, which are sugar oxidoreductases and
biliverdin reductase.
Materials and Methods
Preparation of overexpression plasmids to generate Irp3 protein with N- and C-terminal
histidine tags
To generate a plasmid that produces Irp3 protein with a C-terminal histidine tag, the irp3
gene was amplified from Yersinia enterocolitica 33114 genomic DNA (ATCC) by
polymerase chain reaction by use of Master Mix (Eppendorf) supplemented with the 25 mM
magnesium solution. The forward primer (5’-ATT CTT CAT ATG CCG TCC GCC TCC
CCA AAA CA-3’) includes an NdeI site (underlined), whereas the reverse primer (5’- GGA
TCC CTC GAG CGC CTC CTT ATC ATC ATC GTT G-3’) contains a XhoI site
(underlined). The amplified 1119 basepair fragment was digested with NdeI and XhoI and
ligated into the pET29b plasmid (Novagen) digested with the same enzymes. The resulting
plasmid encodes the irp3 gene with a C-terminal histidine tag (Irp3-his6-C).
The plasmid to produce Irp3 protein with a N-terminal histidine tag was generated by
polymerase chain reaction by use of Herculase II (Agilent) using the Irp3-his6-C plasmid for
the template, the Irp3-his6-C forward primer, and a reverse primer (5’- GGA TCC CTC
GAG TCA CAG CGC CTC CTT ATC ATC ATC GTT G-3’) containing a XhoI site
(underlined) and a stop codon. The amplified 1122 basepair fragment was digested with
NdeI and XhoI and ligated into the pET28b plasmid (Novagen) digested with the same
enzymes. The resulting plasmid encodes the irp3 gene with an N-terminal histidine tag (N-
his6-Irp3).
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Irp3-his6-C protein overexpression and purification
BL21 (DE3) E. coli containing the Irp3-his6-C expression plasmid were grown in LB broth
containing 50 μg/mL kanamycin at 22 °C with shaking (225 rpm). The cells were harvested
by centrifugation (6 000g, 10 min, 4 °C) after 24 h. The cell pellet was resuspended in 15
mL of 25 mM Tris-HCl pH 8, 500 mM NaCl, 5 mM imidazole (buffer A) per liter of culture.
Cells were disrupted by use of a French pressure cell (35 000 psi), and cellular debris was
removed by centrifugation (12 000g, 30 min, 4 °C). The supernatant was applied to a
chelating sepharose fast-flow column (Amersham Biosciences) charged with nickel chloride
and pre-equilibrated in buffer A. Irp3-his6-C protein eluted at 300 mM imidazole in a linear
gradient of 5-500 mM imidazole in buffer A. The pooled fractions were applied to a
Superdex 200 size-exclusion column (Amersham Biosciences) equilibrated with 25 mM
Tris-HCl pH 8, 200 mM NaCl, 2 mM dithiothreitol. The fractions containing Irp3-his6-C
were pooled and concentrated by use of an Amicon stirred cell with a YM-30 membrane to
19 mg/mL as determined by the Bradford assay and stored at -80 °C.
N-his6-Irp3 protein overexpression and purification
BL21 (DE3) E. coli containing the N-his6-Irp3 expression plasmid were grown in LB broth
containing 50 μg/mL kanamycin at 37 °C with shaking (225 rpm). When an optical density
of ~0.6 was reached, the temperature was reduced to 25°C. Protein expression was induced
with the addition of isopropyl β-D-thiogalactopyranoside to a final concentration of 200
μM. The cells were harvested by centrifugation (6 000g, 10 min, 4 °C) after ~18 h. The cell
pellet was resuspended in 10 mL of buffer A per 4 liters of culture and purified similar to
Irp3-his6-C with a nickel charged chelating sepharose fast-flow column followed by a
Superdex 200 size-exclusion column (Amersham Biosciences) equilibrated with 50 mM
potassium phosphate pH 8, 100 mM sodium citrate. The fractions containing N-his6-Irp3
were pooled and concentrated by use of an Amicon stirred cell with a YM-10 membrane to
19 mg/mL as determined by the Bradford assay and stored at -80 °C.
Selenomethionine-substituted (SeMet) N-his6-Irp3 protein overexpression and purification
The method for overexpression of SeMet N-his6-Irp3 was adapted from the protocol of Van
Duyne et al. (9) with several modifications. BL21 (DE3) E. coli containing the N-his6-Irp3
expression plasmid were grown in M9 minimal medium containing 50 μg/mL kanamycin
and inoculated with 20 ml of overnight culture (grown in LB) per liter of medium at 37 °C
with shaking (225 rpm). When an optical density of ~0.6 was reached, the temperature was
reduced to 25 °C and the methionine biosynthesis pathway was inhibited by the addition of
100 mg each of L-lysine, L-phenylalanine, and L-threonine; 50 mg each of L-isoleucine, L-
leucine, and L-valine; and 60 mg of DL-selenomethionine per liter of culture. Fifteen
minutes after the addition of the amino acid mixture, protein expression was induced with
the addition of isopropyl β-d-thiogalactopyranoside to a final concentration of 200 μM.
Cultures were grown for ~18 hours. SeMet N-his6-Irp3 was purified using the same protocol
as that used for N-his6-Irp3 with the addition of 1 mm β-mercaptoethanol to all buffers.
Crystallization of SeMet N-his6-Irp3
SeMet N-his6-Irp3 protein was crystallized using the hanging drop method at 24 °C with
drops containing 1.5 μL of purified protein mixed with equal volumes of a reservoir solution
composed of 0.1 M HEPES pH 7.5, 29% PEG 3350 (w/v), 0.225 M ammonium citrate.
Large crystals (25 × 75 × 150 m) formed after 1-2 weeks. For data collection, crystals were
transferred to the reservoir solution supplemented with 20% ethylene glycol (v/v) as a
cryoprotectant and flash cooled by plunging into liquid nitrogen.
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Crystallization was carried out by the hanging drop method at 24 °C. Drops containing 1.5
μL of purified Irp3-his6-C protein supplemented with 1 mM dichloroethylene-
diaminoplatinate were mixed with equal volumes of a reservoir solution composed of 0.1 M
HEPES pH 7.3, 32% PEG 3350 (w/v), 0.25 M lithium sulfate. Large crystals (50 × 100 ×
150 μm) formed after 1-2 weeks. For data collection, crystals were serially washed in
reservoir solution supplemented with 20% ethylene glycol (v/v) as a cryoprotectant and
flash cooled by plunging into liquid nitrogen.
Crystallization of N-his6-Irp3 with NADP+ bound
N-his6-Irp3 was crystallized using the hanging drop method at 24 °C with drops containing
1.5 μL of purified N-his6-Irp3 protein supplemented with 3 mM NADP+ (Sigma) mixed
with equal volumes of a reservoir solution composed of 0.1 M Tris-HCl pH 8.0, 13% PEG
3350 (w/v), 0.11 M magnesium formate. Rod crystals (25 × 25 × 150 μm) formed after 1-2
weeks. For data collection, crystals were transferred to the reservoir solution supplemented
with 6 mM NADP+ and 20% ethylene glycol (v/v) as a cryoprotectant and flash cooled by
plunging into liquid nitrogen.
Data collection and structure solution of SeMet N-his6-Irp3
Multiwavelength anomalous dispersion data were collected at the Stanford Synchrotron
Radiation Laboratory (Stanford, CA) beamline 9-2. Peak (0.97915 Å), inflection (0.97944
Å), and remote (0.91837 Å) wavelengths were determined by a selenium fluorescence scan.
Data (180°) were collected as 0.3° oscillation images (2 s exposure per frame) with a crystal
to detector distance of 295 mm at 100 K. The crystals were assigned to the space group
P212121 with unit cell dimensions a = 83 Å, b = 93 Å, and c = 181 Å. The data were indexed
and scaled to 2.60 Å using the XDS program package (10). AutoSolve and AutoBuild from
the PHENIX software package (11) were used to determine the location of 23 selenium
atoms (figure of merit = 0.41, overall score = 40.5), to calculate initial phase estimates, and
to build the initial model with 1275 of the possible 1460 residues. Data processing and
phasing statistics are provided in Table 1.
Data collection and structure solution for Irp3-his6-C, considered the “native” structure
Irp3-his6-C diffraction data (0.5° oscillation images for a total of 90.5°) were collected at the
Stanford Synchrotron Radiation Laboratory (Stanford, CA) beamline 9-2 with a wavelength
of 1.000034 Å at 100 K. The exposure time per frame was 5 s with a crystal to detector
distance of 250 mm. The data were indexed with MOSFLM (12) and scaled with SCALA in
the CCP4 program package (13) to 1.85 Å. The crystals were assigned to the space group
P212121 with unit cell dimensions a = 83.87 Å, b = 93.90 Å, and c = 181.12 Å. Because the
SeMet and native data were isomorphous, the initial SeMet model and phase estimates were
used to build the higher resolution native Irp3 model. Model building and refinement of the
structure were accomplished using Coot (14) and Refmac5 (15) from the CCP4 software
suite. Waters were added manually using the water addition function in Coot, and suggested
positions were manually verified in Coot following a refinement cycle in Refmac. Molecules
from the crystallization solution were also modeled (sulfate, ethylene glycol and HEPES).
Alternate conformations were tested for several residues, but in the end are not found in the
final model since the density did not justify their inclusion. Data collection and refinement
statistics are found in Table 2.
Data collection and structure solution for NADP+-bound N-his6-Irp3
Oscillation images of N-his6-Irp3 crystals grown in the presence of NADP+ (90° with an
oscillation angle of 0.6°) were collected at the Stanford Synchrotron Radiation Laboratory
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(Stanford, CA) beamline 9-2 with a wavelength of 0.97949 Å at 100 K. The exposure time
per frame was 25 s with a crystal to detector distance of 330 mm. The data were indexed and
scaled to 2.3 Å with XDS (10). The crystals were assigned to the space group P212121 with
unit cell dimensions a = 83.42 Å, b = 93.82 Å, and c = 181.99 Å. Molecular replacement
calculations were performed using the program PHASER (16) and the data from 38.0 to 2.3
Å. Molecule A of the Irp3-his6-C native structure was used as a search model yielding a
clear solution with a log likelihood gain of 12,806.61. The map generated with this solution
showed unmodeled electron density in the active site corresponding to the NADP+ and an
additional 15 residues at the N-terminus of molecule A compared with the native Irp3-his6-C
model. These differences in electron density relative to the molecular replacement model
indicate a correct solution. Iterative rounds of model building and refinement were
performed with Coot (14) and Refmac5 (15). Waters were added manually using the water
addition function in Coot, and suggested positions were manually verified in Coot following
a refinement cycle in Refmac. Data collection and refinement statistics are found in Table 2.
Native Irp3 crystallographic model
The final native Irp3 model contains four monomers per asymmetric unit. The ordered
residues in the structure can be found in Table 3. The structure also includes four sulfate
ions, one HEPES molecule, and two ethylene glycol molecules from the crystallization
conditions and 498 water molecules. Ramachandran analysis as calculated by RAMPAGE
(17) showed good geometry (Table 2). The amino acids in the outlier region were
glycine-276 in monomers A, B and C.
NADP+-bound Irp3 crystallographic model
The final native Irp3 model contains four monomers per asymmetric unit. The ordered
residues in the structure can be found in Table 3. The structure also includes one NADP+ in
each active site and 110 water molecules. Ramachandran analysis as calculated by
RAMPAGE (17) showed good geometry (Table 2). The amino acids in the outlier region
were glycine-276 in all monomers, and proline-2 in monomer A.
Structural analysis
Root mean square deviations (r.m.s.d.) were calculated using LSQMAN program suite (18).
Structural comparisons (including r.m.s.d. calculations therein) were carried out using the
PDBeFold (19) and protein interaction interfaces were analyzed using PDBePISA (20), both
of the European Bioinformatics Institute server (http://www.ebi.ac.uk/pdbe/). Protein
structure figures were generated using PyMOL (21). The atomic coordinates and structure
factors (codes 4GMF and 4GMG) have been deposited in the Protein Data Bank, Research
Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ
(www.rcsb.org).
Homology model of PchG
Using monomer A of the Irp3 native structure, a model of the Pseudomonas aeruginosa
thiazolinyl imine reductase, PchG, was built with the SWISS-MODEL fully automated
protein structure homology modeling server (http://swissmodel.expasy.org) (22, 23).
Results
Preparation of Irp3
Irp3 protein was cloned into both the pET28b and pET29b vectors and overproduced in
BL21(DE3) E. coli to produce protein with either an N- or C-terminal histidine tag (N-his6-
Irp3 and Irp3-his6-C, respectively). Protein purification was completed in two steps using
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nickel chelating chromatography followed by gel filtration chromatography. The ~40 kDa
protein eluted from the gel filtration column at a molecular weight consistent with an 80 kDa
protein, indicating dimer formation in solution. This purification protocol yielded 100 mg N-
his6-Irp3 per liter of culture and 24 mg Irp3-his6-C per liter of culture at a purity estimated
to be >90% by polyacrylamide gel electrophoresis. The N-his6-Irp3 was also produced in a
selenomethionine-substituted form, with a yield of 24 mg per liter of culture. The SeMet
protein was purified using a similar protocol, with the addition of a reducing agent to all
buffers. All three forms of the protein were crystallized using PEG 3350 as the precipitant,
but with differing buffers and salt additives. The Irp3-his6-C and SeMet N-his6-Irp3 were
crystallized without ligands. N-his6-Irp3 without selenomethionine substitution was
crystallized in the presence of NADP+.
Overall architecture of Irp3
Initial phase estimates for N-his6-Irp3 were determined by multiwavelength anomalous
dispersion phasing using a selenomethionine-substituted form of the protein (Table 1). The
Se-Met model was used as a starting point for model building and structure refinement with
the 1.85 Å isomorphous native (Irp3-his6-C) dataset. The high resolution native model was
used for molecular replacement to solve the NADP+-bound (N-his6-Irp3) structure to 2.31 Å
(Table 2). In both structures, the asymmetric unit contains four monomers of Irp3, arranged
as two dimers (Figures 2A and 2B). For each dimer, the two monomers are related by a non-
crystallographic two-fold axis, and the two dimers are related by a translation roughly along
this axis.
Monomer architecture
Each monomer is composed of two domains. The N-terminal domain is a Rossmann fold
(24) comprising residues 7-125 with a helix donated from the C-terminal domain (residues
285-310) packing against the central 6-stranded parallel β-sheet (Figure 2B). The faces of
the β-sheet are packed with two or three α-helices. The C-terminal domain (residues 126 –
284 and 311 – 337) is an eight stranded mixed (nearly antiparallel) β-sheet with three α-
helices packed on one side. The N-his6-Irp3 NADP+-bound structure includes electron
density for residues 1-6 and eight residues of the N-terminal purification tag (residues -7 to
0) of monomer A. Residues -7 to 1 form an additional crystal contact with monomer C.
Residues 339 to 357 are evident in all four monomers of both the Irp3-his6-C native and N-
his6-Irp3 NADP+-bound structures. Residues 338 to 350 are a random coil with the last
seven residues (351 to 357) forming helix 9, which contributes to the dimerization interface.
In Irp3, a further eight amino acids are disordered at the C-terminus, as well as one
(NADP+-bound structure) or two or three (native structure) internal loops (Table 3). Finally,
we note that the previously hypothesized transmembrane region (residues 162-182, (6))
comprises helix 6 and the 6-H loop, and does not play the role suggested.
Comparison of native and NADP+-bound structures
The overall architecture of the native and NADP+-bound structures is quite similar (Figure
3A). The root mean square deviations for comparison between monomers of the same
structure (native monomer A to native monomer B, for example) range from 0.22 to 0.55 Å
for 328 to 343 Cα residues. Comparison of monomers between structures (native monomer
A to NADP+-bound monomer A, etc.) yielded values ranging from 0.31 to 0.60 Å for 326 to
331 Cα residues. Binding of NADP+ causes the ordering of the loop connecting strand D
and helix 3, which is disordered in all four monomers of the native structure (Table 3).
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A search with the PDBeFold server (19) revealed that the closest structurally related
enzymes for which a function has been determined belong predominantly to the
GFO_IDH_MocA oxidoreductase family and also the dimeric dihydrodiol dehydrogenase.
There are many structures with similarity to Irp3 that have been deposited by structural
genomics consortia with little annotation, but labeled “oxidoreductase” or “dehydrogenase.”
The fold similarity is evident, even by eye (Figure 4). For the top 100 hits, the Z-scores
range from 12.2 to 9.7, with a range in r.m.s.d. for these same comparisons of 2.2 to 2.9 Å
aligning 235-265 α-carbons with 8-17% sequence identity. More simply, this means that the
structure of Irp3 falls into the general structural class of oxidoreductase. This comparison
led us to compare the structure Irp3 to the sugar oxidoreductases of known function, with
hopes of deducing functional significance. These enzymes include the glucose-fructose
oxidoreductase from Zymomonas mobilis (GFOR, (25, 26)), the 1,5-anhydro-D-fructose
reductase from Sinorhizobium morelense (AFR, (27)), monkey dimeric dihydrodiol
dehydrogenase (DHDH, (28-30)), WlbA from Bordetella pertussis and Chromobacterium
violaceum, which are required to oxidize a C-3’ hydroxyl group of a UDP-linked sugar for
formation of 2,3-diacetamido-2,3-dideoxy-D-manuronic acid (31, 32), and KijD10, a
ketoreductase in the biosynthetic pathway of L-digitoxose derived from the bacterium
Actinomadura kijaniata (33). Irp3 was also compared to biliverdin reductase (34, 35) and
mouse major urinary protein (36), since Irp3 had previously been hypothesized to be
structurally similar to these proteins (5). Biliverdin reductase is roughly as structurally
similar to Irp3 as the oxidoreductases identified by PDBeFold, with an r.m.s.d. of 1.88 Å for
199 Cα's. Mouse major urinary protein, which is a β-barrel, shares no structural similarity
with Irp3.
Dimerization interface
The open side of the β-sheet of the C-terminal domain comprises the most extensive part of
the dimerization interface, a common oligomerization motif in this class of enzymes (25, 29,
31, 33, 37), with an additional interaction from the C-terminal tail (Figures 2A and 2B).
Interestingly, GFOR has an N-terminal “arm” that seems to perform a similar role,
controlling oligomerization (26). Analysis in PDBePISA (20) shows that the interface
between the A and B monomers (dimer 1) and C and D monomers (dimer 2) range from
3260 – 3300 Å2, with an average of 3280 Å2. No higher order oligomers are evident in the
structure, consistent with the dimer observed in solution.
NADP+ binding
The N-terminal, NADP+-binding domain of Irp3 is a Rossmann fold with a topology like
that found in lactate and malate dehydrogenase (38). None of the canonical consensus
sequences for cofactor binding (for example, GXGXXG) are found (38-40). Nevertheless,
there is a glycine rich sequence 14GAKFGE19 in the first loop of the first βαβ motif to
which the NADP+ binds. As is seen in GFOR, an aromatic amino acid stacks with the
nicotinamide ring on the side away from the substrate binding site. A tyrosine is observed in
GFOR (25, 37) and a phenylalanine (residue 17) is found at this site in Irp3 (Figure 3B).
Unlike the GFOR and AFR, Irp3 does not have a kink in the first helix from the inclusion of
a proline or glycine in the third turn, which is proposed to influence the helix dipole moment
(27).
The NADP+-bound structure has clear density for the cofactor (Figure 3B). We assume that
the cofactor remained oxidized, but the electron density of the nicotinamide ring is
insufficient to determine whether the cofactor is oxidized (planar) or became reduced (not
planar). The density is sufficient for a supposition of stereochemistry. The nicotinamide ring
is bound in the anti conformation, which is consistent with the A-side specific
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oxidoreductases (27, 33) and in contrast to the B-side specific biliverdin reductase (35),
suggesting that Irp3 may also be A-side specific. In Irp3, the D-3 loop becomes ordered
upon binding of NADP+ (yellow loop in Figure 5A). KijD10 with NADP+ and a substrate
analogue bound crystallized in “open” and “closed” conformations in which the
nicotinamide ring was syn and anti, respectively. An extended loop in KijD10 (grey in
Figure 5) undergoes a disorder to order transition from an open to a closed conformation,
which is hypothesized to be responsible for the change in conformation of the nicotinamide
ring (from syn to anti). Note that the loops that become ordered upon binding of NADP+ in
Irp3 and KijD10 are not comparable. The loop that became ordered in KijD10 is comparable
to the G-6 loop of Irp3. The adenine ring is bound in the anti conformation in Irp3. In the
determined structures of the oxidoreductases (27, 31-33), the conformation of the adenine is
varied, with both anti and syn observed.
In GFOR, AFR and DHDH, there is a second consensus sequence for cofactor binding. In
GFOR and AFR, this sequence is GX2VXCEKP (25, 27) and in DHDH it is HX2HX16EKP
(28-30), with the last residues being most important (EKP). The glutamic acid hydrogen
bonds to the carboxyamide of the nicotinamide ring. The proline residue is in the cis
configuration which allows for positioning of the lysine residue into the active site to form a
cation-π interaction with the nicotinamide ring (27). In WlbA and KijD10, the EKP
sequence is conserved although the remainder of the longer consensus sequence is not found
(31, 33), whereas biliverdin reductase has an EYP sequence at this site (35). Irp3
has 100EHP102 in the comparable loop (Figures 3B and 5B), the glutamic acid is H-bonded
to the carboxyamide of the nicotinamide ring, the proline is cis, and the histidine is 3.5 – 4.0
Å from the carboxyamide of the nicotinamide ring.
Substrate binding
A consensus sequence for substrate binding has been hypothesized for GFOR/AFR/DHDH:
GGX3DX3(Y/H) (28, 29), originally proposed from sequence alignment studies of DHDH
(41). This sequence is found at the C-terminus of a 28-residue loop and includes the N-
terminal two turns of an active site α-helix (Figure 4 lower panels). In GFOR (37), KijD10
(33), and WlbA from Bordetella pertussis (31), which also have the GGX3DX3(Y/H)
substrate binding consensus sequence (grey in Figure 5 for KijD10), the aspartic acid is
hypothesized to be important for substrate binding. The final amino acid of the sequence has
been hypothesized to serve as the general acid/general base for catalysis. Biliverdin
reductase does not have the consensus sequence, but the comparable loop/helix is extensive
(19 residues in all) and similarly located. Irp3 does not have the consensus sequence nor the
loop. Instead, the comparable loop connecting the G strand to the 6 helix is five residues
(residues 157-162) and the helix is a turn shorter, effectively removing this potential
substrate specificity determinant (cyan in Figure 4). BVR and Irp3 have a serine (166 in
Irp3) at the structurally equivalent site to the (Y/H) of the consensus sequence. Irp3 has a
tyrosine (128) derived from the linker between the N- and C-terminal domains (loop F-5)
that is in a similar three-dimensional location and hydrogen bonded to the carboxyamide of
the nicotinamide of NADP+ (Figure 5B). The orange loop of Irp3 in Figures 4 and 5
connects the J and K strands, occupies the space filled in the other proteins by the
comparable G-6 loop, and may provide the specificity determinants for substrate binding.
Interestingly, the putative substrate binding site in Irp3 is filled in part by the very long loop
(residues 250 – 277) which connects the M and N strands from the opposing monomer (M’-
N’ blue loop in Figure 5). A portion of the M-N loop is disordered in the structure, the
number of disordered residues depending on the monomer (Table 3). This very long loop is
unique to Irp3 compared to the others of this structural class, as seen best in Figure 4 (upper
panels). The sugar oxidoreductases have a short turn connecting the strands comparable to
M and N. Indeed, BVR does not have strands comparable to M and N.
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Homology model of PchG
Using the fully automated protein structure homology modeling server SWISS-MODEL
(http://swissmodel.expasy.org) (22, 23), and the native Irp3 structure as a template, a model
of the thiazolinyl imine reductase involved in pyochelin production from Pseudomonas
aeruginosa (PchG) was generated (Figure 6). The sequence identity between the proteins is
26%, with Irp3 comprising 365 residues and PchG containing 349 residues. The PchG
model includes residues 4 to 336, with the majority of the unmodeled residues at the C-
terminus. The QMEAN score for the PchG model of -0.757 indicates that the model is of
good quality (42), and as expected, the overlay of the PchG model with the Irp3 determined
structure shows a marked degree of similarity (r.m.s.d. of 0.464 Å for 315 Cα; Figure 6),
including a high conservation of active site residues. The notable difference is in the loop
connecting strands M and N, which is partially disordered in the Irp3 structure but built in
the PchG model and includes two additional short β-strands.
Discussion
Dimerization may promote binding of substrate
This work provides the first structures of a thiazolinyl imine reductase important in
siderophore biosynthesis, including an apo-Irp3 crystal structure, Irp3 with NADP+ bound,
and a homology model for PchG generated from the Irp3 structures. An N-terminal
Rossmann fold nucleotide binding domain is followed by a C-terminal substrate binding
domain, with the active site cleft lying between the two domains. The closest structural
homologues are sugar oxidoreductases, along with dihydrodiol dehydrogenase and
biliverdin reductase. The structural homologues range in oligomerization state from
monomeric to octameric. In solution and in the crystal, Irp3 is dimeric, using the open face
of the β-sheet in the C-terminal domain as the most extensive dimeric interface (Figure 2).
The question of dimerization in this structural class has been tested in DHDH, where dimer
interface mutations were generated and shown to result in active but temperature sensitive
monomers, suggesting dimerization promotes stability and thus activity (28). This may also
be true in Irp3.
The substrate for Irp3 (depicted in Figure 1) is covalently bound to the peptidyl carrier
domain of the very large HMWP1 (350 kDa), consisting of both polyketide synthase and
nonribosomal peptide synthetase modules (8, 43). The substrate is bound to the peptidyl
carrier domain of the NRPS module (8). Neither the structure nor the oligomerization state
of HMWP1 are documented; however, there is evidence for oligomerization of polyketide
synthases (44-46) and the predominance of evidence supports monomers for nonribosomal
peptide synthetases (47-49). Binding of dimeric Irp3 to HMWP1 (monomeric or dimeric)
allows for insertion of the substrate covalently attached to the peptidyl carrier domain of
HMWP1 into the active site of Irp3. This binding, which is a catalytic interaction and is
most likely transient, may be facilitated by two loops on Irp3. The M-N loop of Irp3 is very
long compared to the comparable loop in homologous proteins (~ 25 residues longer). This
loop from one monomer projects into the active site of the opposing monomer (Figure 5),
with some residues disordered. While the precise placement of the loop may be
crystallographic, dimerization orients the M-N loop for participation in binding of HMWP1.
If this is true, the C-terminal tail may also be involved in binding to HMWP1, due to
proximity to the M-N loop, instead of serving an additional role in Irp3 oligomerization.
These extended loops (the M-N loop and the C-terminal tail) are conserved in PchG
(homology model depicted in Figure 6). The potential functional role may be conserved as
well, with the comparable loops in PchG promoting interaction with PchF, the NRPS to
which the PchG substrate is covalently attached. Finally, the G-6 loop is significantly shorter
in the thiazolinyl imine reductases relative to the sugar oxidoreductases, preventing this loop
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from involvement in binding of the substrate. Instead, the J-K loop is extended and occupies
a similar location in three dimensions, possibly providing binding residues for the
siderophore biosynthetic intermediate (Figures 4 and 5).
Implications for catalysis
A mechanism has evolved in the literature for the sugar oxidoreductases that includes a
general acid/base residue for donation or abstraction of a proton from substrate and donation
of a hydride to/from the nicotinamide cofactor to the substrate, depending on whether
oxidation or reduction of a carbon-oxygen bond is being undertaken (25, 27, 31, 33). A
similar mechanism is proposed for reducing the carbon-carbon bond in biliverdin, with a
proton donated from a tyrosine general acid and a hydride donated from the C4 of the
nicotinamide (35). The residue hypothesized to serve as the general acid/base has been
hypothesized to be to be 1) the middle residue of the EKP consensus sequence (31, 33, 35)
(tyrosine in BVR) or 2) the final residue of the GGX3DX3(Y/H) consensus sequence (25,
27-29). These hypotheses have been tested by mutagenesis. In AFR, the K94G-variant
(EKP) and the H180A-variant (GGX3DX3(Y/H)) produced similar changes in kinetic
parameters leading the authors to suggest that these residues were important in substrate
binding and catalysis (27). In KijD10, a battery of K102-variants (EKP) either had no
activity, or in the case of K102E, a reduction of four orders of magnitude in kcat/Km,
whereas the Y186F-variant (GGX3DX3(Y/H)) showed mostly unchanged kinetic
parameters. The authors propose the lysine of EKP to be the general acid/base with the
glutamic acid of the K102E-variant serving the role ineffectively (33). In BVR, the tyrosine
that corresponds to the lysine of EKP has been mutated to phenylalanine, producing the
Y97F-variant, which showed 50% of the activity of wildtype. The authors conclude that Y97
is the general acid, but that the hydride transfer from NADPH was the dominant process in
catalysis (35). BVR does not contain the GGX3DX3(Y/H) consensus sequence, and neither
do Irp3 or PchG. However, there is a structurally equivalent residue at the (Y/H) site, which
is serine (a possible general acid) in BVR and Irp3 and alanine (incapable of serving as a
general acid) in PchG. Taken together, the middle residue at the EKP sequence is the more
likely the general acid/base, especially considering the following conserved cis-proline for
orientation of the acid/base in the proper conformation. Therefore, by analogy, histidine-101
of Irp3 (EHP) is the general acid required for catalysis, which is conserved in PchG
(histidine-97). However, we cannot rule out that tyrosine-128 of Irp3 that is derived from
loop connecting strand F on the N-terminal domain to helix 5 of the C-terminal domain
which is in a similar location to the final residue of the GGX3DX3(Y/H) in the sugar
oxidoreductases may also serve as a general acid (Figure 5B). This residue is conserved in
PchG (tyrosine-124), but not in the other proteins under discussion.
Conclusions
Thiazolinyl imine reductases (Irp3 and PchG) are dimeric enzymes with structural similarity
to sugar oxidoreductase such as GFOR, AFR, KijD10 and WlbA and to biliverdin reductase.
Irp3 and PchG may interact with the nonribosomal peptide synthetase modules to which
their substrates are attached using loops that are unique from their structural homologues.
The reduction of the C-N double bond of the substrate thiazoline ring is hypothesized to be
carried out by proton donation from a general acid, most likely histidine-101 or alternatively
tyrosine-128, and hydride transfer from C4 of the nicotinamide of the NADPH cofactor.
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Abbreviations
AFR 1,5-anhydro-D-fructose reductase from Sinorhizobium morelense
BVR rat biliverdin reductase
DHDH monkey dimeric dihydrodiol dehydrogenase
GFOR glucose-fructose oxidoreductase from Zymomonas mobilis
HMWP1 high molecular weight protein 1, a nonribosomal peptide synthetase from
Yersinia enterocolitica
Irp3 thiazolinyl imine reductase from Yersinia enterocolitica
Irp3-his6-C Irp3 with a C-terminal histidine purification tag
KijD10 a ketoreductase from Actinomadura kijaniata
N-his6-Irp3 Irp3 with an N-terminal histidine purification tag
NRPS nonribosomal peptide synthetase
Ppant phosphopantetheine
PchD salicylate adenylase from Pseudomonas aeruginosa
PchE nonribosomal peptide synthetase from Pseudomonas aeruginosa
PchF nonribosomal peptide synthetase from Pseudomonas aeruginosa
PchG thiazolinyl imine reductase from Pseudomonas aeruginosa
r.m.s.d. root mean squared deviation
SeMet selenomethionine
WlbA from Bordetella pertussis, Chromobacterium violaceum and Pseudomonas
aeruginosa, enzymes involved in 2,3-diacetamido-2,3-dideoxy-D-
manuronic acid production
YbtU thiazolinyl imine reductase from Yersinia pestis
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Figure 1. Yersiniabactin, pyochelin, and biliverdin
Yersiniabactin, the siderophore produced by Yersinia spp., is the product of the biosynthetic
pathway to which Irp3 belongs. Irp3 reduces a double bond in the center thiazoline ring to
make the thiazolidine ring of the product. The substrate is reduced while covalently attached
to a phosphopantetheinyl post-translational modified serine of the peptidyl carrier domain of
the High Molecular Weight Protein 1 (HMWP1). (B) Pyochelin is a siderophore produced
by Pseudomonas aeruginosa. PchG performs the analogous reaction as Irp3. The substrate is
reduced while covalently attached to a phosphopantetheinyl post-translational modified
serine of the peptidyl carrier domain of the nonribosomal peptide synthetase PchF. This ring
is subsequently methylated by the methylation domain of PchF. (C) Biliverdin is the
substrate of biliverdin reductase, an enzyme which catalyzes the final step in heme
degradation, reducing the center methylene bridge to form bilirubin. Biliverdin reductase is
a structural homologue of Irp3, as found herein.
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Figure 2. Overall architecture of Irp3
(A and B) Dimeric structure of Irp3. The A monomer is shown in yellow. The B monomer is
shown in blue (N-terminal domain) and green (C-terminal domain), with the C-terminal tail
shown in magenta. Parts (A) and (B) are related by a 90° rotation about the x-axis. The
dimerization interface is evident where the open sides of the β-sheet in the C-terminal
domains pack together. The magenta helix of the C-terminal tail packs against the opposing
monomer, also contributing to the dimerization interface. Monomers A and B of the native
structure are depicted. (C) Stereoview of monomer. The N-terminal, NADP(H) binding
domain (residues 1-125) is blue, with the helix donated from the C-terminus shown in dark
blue (residues 285-310). The C-terminal substrate binding domain is shown in green
(residues 126-284 and 311 – 338). The C-terminal tail is shown in magenta. Strands are
denoted by letters A – N, starting from the N-terminus. Helices are counted from the N-
terminus, 1-8. Monomer A of the native structure is depicted.
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Figure 3. NADP+ binding
(A) Superposition of the native Irp3 structure (grey) with the NADP+-bound structure. The
domains of the NADP+-bound structure are colored as in Figure 2, with the addition of the
N-terminal tail, show in pink. The NADP+ is depicted as yellow sticks. The sulfate ion
bound in the NADP + binding site of the native structure is also shown in sticks. The A
monomers of both structures are overlayed. (B) Fo – Fc difference density contoured at 3σ
(grey cages) for the NADP+. Phenylalanine-17 is part of the glycine rich 14GAKFGE19
sequence for nucleotide binding. The functionally important 100EHP102 sequence is also
shown, as is tyrosin-128. Oxygen atoms are red, nitrogen atoms are dark blue, and
phosphorous atoms are orange. Carbon atoms are colored as per the molecule: Irp3, light
green; NADP+, yellow.
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Figure 4. Cartoon representations of the NADP+-bound Irp3, 1,5-anhydro-D-fructoase reductase
(AFR, Protein Data Bank code 2GLX), biliverdin reductase (BVR, code 1LC3), dimeric
dihyrodiol dehydrogenase (DHDH, code 2O48)
The upper panels show the overall fold in cartoon and the NADP+ (or sulfates in DHDH) in
sticks. It should be noted that the NADP+ binds in a similarly extended conformation in Irp3
and AFR. In BVR, the NADP+ is folded in a U-shaped conformation that is hypothesized to
be the result of crystal packing (35). The DHDH structure does not contain NADP+, but has
sulfates bound in locations similar to where the phosphates of NADP+ are anticipated to
bind (30). In Irp3, the M-N loop, which has 6 to 15 residues disordered depending on
monomer, is labeled. The lower panels are a close-up of the putative substrate binding
region. In DHDH, the region of the GGX3DX3(Y/H) consensus sequence is shown in light
grey and the remainder of the loop containing this sequence is black. The corresponding
loops in AFR and BVR are also grey. In Irp3, the much shorter loop connecting strand G
and helix 6 is shown in cyan. The extended loop connecting the J and K strands that
occupies the corresponding space in three-dimensions is shown in orange.
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Figure 5. Overlay of the Irp3 and KijD10 active sites, highlighting differences in loops (A) and
residues (B)
The colors are maintained in the (A) and (B) panels: NADP+-bound Irp3 is shown in green
cartoon. KijD10 (PDB code 3RC1) is shown in pink cartoon. The NADP+ bound in the
active sites are shown as yellow (Irp3) and magenta (KijD10) sticks. The substrate analogue,
dTDP-benzene, for KijD10 is also shown in magenta sticks. KijD10 is a member of the
glucose-fructose oxidoreductase family, and contains the GGX3DX3(Y/H) consensus and
following loop shown as the grey cartoon, similar to Figure 4. The D-3 loop of Irp3 is shown
in yellow. The J-K loop of Irp3 is shown in orange. The blue cartoon is for the M’-N’ loop
of the opposing dimer, which would be connected by six disordered residues (256-261). (A)
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The grey loop in KijD10 undergoes a disorder to order transition when the protein goes from
the open to the closed conformation, and with this transition, the nicotinamide of the
NADP+ flips from syn to anti (33). The nicotinamide ring in Irp3 is anti as seen in the closed
conformation of KijD10 shown here. The loop in Irp3 that undergoes a disorder-to-order
transition upon NADP+-binding is the D-3 loop (yellow). The orange (J-K) loop of Irp3 is in
a comparable position to the grey loop of KijD10, but does not contain the consensus
sequence nor does it connect comparable secondary structure (this is the G-6 loop in Irp3) as
discussed in Figure 4. We hypothesize that the very long M’-N’ loop (blue) resides in a
different location in the presence of substrate and aids in binding the protein HMWP1 to
which the substrate is covalently attached. (B) The EKP sequence of KijD10 and the
corresponding EHP of Irp3 are shown in sticks and labeled. The K/H at the center of this
loop is hypothesized to be the general acid, which is supported by mutagenic analyses in
KijD10 (33). The Y186 of the GGX3DX3(Y/H) consensus sequence in KijD10 is displayed
in sticks to show the relative location to S166, the structurally equivalent amino acid, and
Y128, found in the linker between the N-terminal and C-terminal domains (the F-5 loop),
both in Irp3. Labels in bold are for Irp3 and those in plain text are for KijD10.
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Figure 6. Homology model of PchG from Pseudomonas aeruginosa generated with SWISS-
MODEL (22, 23)
The the N-terminal, NADP(H) binding domain of the native Irp3 structure (residues 1-125,
285-310) is blue. The C-terminal substrate binding domain is shown in green (residues
126-284 and 311 – 338). The PchG homology model is shown in purple cartoon. The loop
connecting strands M and N, which is partially disordered in the Irp3 structure, contains two
additional β-strands in the PchG model.
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Wavelength (Å) 0.97944 0.97915 0.91837
Space group P212121 P212121 P212121
Cell dimensions; a, b, c (Å) 82.97, 93.06, 181.37 82.93, 92.97, 181.26 83.00, 93.09, 181.34
Resolution (Å) 51.14 - 2.60 (2.74 - 2.60) 51.11 - 2.60 (2.74 - 2.60) 51.15 - 2.60 (2.74 - 2.60)
R sym 
c 0.106 (0.373) 0.105 (0.366) 0.107 (0.361)
Total observations 325730 (47180) 324939 (47099) 326255 (47276)
Total unique observations 44022 (6307) 43953 (6305) 44045 (6306)
Mean ((I) / sd(I)) 12.5 (4.9) 12.5 (5.1) 12.6 (5.0)
Completeness (%) 100.0 (100.0) 100.0 (100.0) 100.0 (100.0)
Redundancy 7.4 (7.5) 7.4 (7.5) 7.4 (7.5)
Anomalous completeness (%) 100.0 (100.0) 100.0 (100.0) 100.0 (100.0)
Anomalous redundancy 3.8 (3.8) 3.8 (3.7) 3.8 (3.8)
No. of refined selenium sites 23
DelAnom correlation between half-sets
d 0.229 (-0.004) 0.204 (0.011) -0.009 (-0.009)
Mean figure of merit
e 0.41
Mid-Slope of Anom Normal Probability
f 1.124 1.114 0.99
a
All data were collected at beamline 9-2 at the Stanford Synchrotron Radiation Lightsource. Values in parenthesis are for the highest resolution
shells.
b
Data indexed and scaled with XDS
c
Rsym = Σh |Ih - <I>|ΣhIh, where Ih is the intensity of reflection h, and <I> is the mean intensity of all symmetry-related reflections
d
Anoma lous correlation between half-sets = Σ||FPH ± FP| - FHcalc|/Σ|FPH| reported for all centric reflections.
e
Mean figure of merit = <aΣPaeia/ΣPa>, where a is the phase and Pa is the phase probability distribution.
f
Mid-slope of anomalous probability = <|FH|/||FP + FH| - |FPH||> reported for all reflections.
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Table 2





Wavelength (Å) 1.000034 0.97944
Space group P212121 P212121
Cell dimensions; a, b, c (Å) 83.87, 93.90, 181.12 83.42, 93.82, 181.99
Resolution (Å) 76.11 - 1.85 (1.95 - 1.85) 39.89 - 2.31 (2.43 - 2.31)
R sym 
c 0.054 (0.395) 0.087 (0.389)
Total observations 465318 (67058) 234222 (33388)
Total unique observations 122197 (17701) 63447 (9044)
Mean ((I) / sd(I)) 12.4 (3.1) 11.2 (3.2)
Completeness (%) 99.8 (100.0) 99.6 (98.5)
Redundancy 3.8 (3.8) 3.7 (3.7)
Refinement
Resolution (Å) 40.97 - 1.85 (1.90 - 1.85) 39.89 - 2.31 (2.37 - 2.31)
R cryst 
d 19.6 (26.8) 19.7 (25.8)
R free 24.2 (32.8) 26.0 (33.1)
Total unique observations 115,840 60,174





rms deviation bonds (Å) 0.02 0.015
rms deviation angles (°) 2.01 1.93
Overall mean B-factor (Å2) 28.3 28.7
Ra machandran plot analysis
e
Favored region 98.4 96.9
Allowed region 1.4 2.9
Outlier region 0.2 0.3
a
All data were collected at beamline 9-2 at the Stanford Synchrotron Radiation Lightsource. Values in parenthesis are for the highest resolution
shells.
b
native data indexed with MOSFLM and scaled with Scala, NADP+ data indexed and scaled with XDS
c
Rsym = Σh |Ih - <I>|/Σh Ih, where Ih is the intensity of reflection h, and <I> is the mean intensity of all symmetry-related reflections
d
Rcryst = Σ ||Fo| - |Fc||/Σ |Fo|, Fo and Fc are observed and calculated structure factor amplitudes. Five percent of the relections were reserved for
the calculation of Rfree.
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e
Calculated with RAMPAGE
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Table 3
Ordered amino acids in structures by monomeric chain
Residues in model Native NADP+ bound
Monomer A 7 - 75, 78 - 255, 270 - 357
-7 - 254,
a
 262 - 357
Monomer B 8 - 26, 31 - 74, 78 - 255, 270 - 357 7 - 255, 262 - 357
Monomer C 7 - 27, 31 - 74, 78 - 254, 270 - 357 7 - 254, 270 - 357
Monomer D 7 - 74, 78 - 254, 271 - 357 7 - 255, 264 - 357
a
includes 7 N-terminal amino acids of the purification tag
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